Impotence Drug Price-Fixing Investigated

Law360, New York (June 27, 2006, 12:00 AM EDT) -- A Swiss competition administration has begun an investigation into three major drug producers that authorities believe may be fixing prices for impotence drugs.

The authority, WEKO, said that it is looking into Pfizer Inc., Bayer AG and Eli Lilly & Co., saying they charge nearly identical prices for impotence drugs Viagra, Levitra and Cialis.

The organization said it is also worried about over-the-counter drugs being sold at similar prices.

General practitioners and pharmacists are also under scrutiny. In particular, WEKO thinks it’s suspicious that the drugs...
To view the full article, register now.